The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome
出版年份 2022 全文链接
标题
The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 11, Issue 7, Pages 1847
出版商
MDPI AG
发表日期
2022-03-28
DOI
10.3390/jcm11071847
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults
- (2021) Jiaye Liu et al. Clinical Gastroenterology and Hepatology
- MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease
- (2021) Jiaofeng Huang et al. Risk Management and Healthcare Policy
- Evidence-Based Aerobic Exercise Training in Metabolic-Associated Fatty Liver Disease: Systematic Review with Meta-Analysis
- (2021) Joanna Słomko et al. Journal of Clinical Medicine
- Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
- (2021) Donghee Kim et al. JOURNAL OF HEPATOLOGY
- Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey
- (2021) Joon Ho Moon et al. Journal of Cachexia Sarcopenia and Muscle
- Association between sarcopenia and atherosclerosis in elderly patients with ischemic heart disease
- (2020) Shota Uchida et al. HEART AND VESSELS
- Epidemiological feature of NAFLD from 1999 to 2018 in China
- (2020) Jianghua Zhou et al. HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Increasing liver fat is associated with progression of cardiovascular risk factors
- (2020) Katherine T. Brunner et al. LIVER INTERNATIONAL
- Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention
- (2020) Philip O’Gorman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- NAFLD and cardiovascular diseases: a clinical review
- (2020) Philipp Kasper et al. Clinical Research in Cardiology
- Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease
- (2020) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Cachexia, muscle wasting, and frailty in cardiovascular disease
- (2020) Agata Bielecka‐Dabrowa et al. EUROPEAN JOURNAL OF HEART FAILURE
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
- (2020) Mina Wang et al. Frontiers in Endocrinology
- Nonalcoholic Fatty Liver Disease and the Heart
- (2019) Eric P. Stahl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran
- (2019) Nima Motamed et al. CLINICAL NUTRITION
- Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States
- (2019) Pegah Golabi et al. BMC GASTROENTEROLOGY
- Sarcopenia and fatty liver disease
- (2019) Jung A. Kim et al. Hepatology International
- Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index
- (2019) Maki Tobari et al. Gut and Liver
- Non-alcoholic fatty liver disease, a new and growing risk indicator for cardiovascular disease
- (2019) Arne Janssen et al. European Journal of Preventive Cardiology
- Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017
- (2018) Thomas R. Einarson et al. Cardiovascular Diabetology
- Frailty in advanced liver disease
- (2018) Robyn Laube et al. LIVER INTERNATIONAL
- Validity of Japanese version of SARC-F questionnaire in patients with chronic liver disease
- (2018) Satoshi Ida et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease
- (2017) Takashi Shida et al. JOURNAL OF GASTROENTEROLOGY
- Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment
- (2017) Vincent Wai-Sun Wong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
- (2017) Ryuki Hashida et al. JOURNAL OF HEPATOLOGY
- Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis
- (2017) Christina N Katsagoni et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Insulin resistance and sarcopenia: mechanistic links between common co-morbidities
- (2016) Mark E Cleasby et al. JOURNAL OF ENDOCRINOLOGY
- Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
- (2016) Sven M. Francque et al. JOURNAL OF HEPATOLOGY
- Developmental origins of NAFLD: a womb with a clue
- (2016) Stephanie R. Wesolowski et al. Nature Reviews Gastroenterology & Hepatology
- Quadriceps Strength as a Predictor of Mortality in Coronary Artery Disease
- (2015) Kentaro Kamiya et al. AMERICAN JOURNAL OF MEDICINE
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Effects of growth hormone–releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies
- (2015) Takara L. Stanley et al. GROWTH HORMONE & IGF RESEARCH
- The Implications of Sarcopenia and Sarcopenic Obesity on Cardiometabolic Disease
- (2015) Tae Nyun Kim et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- External Validation of Fatty Liver Index for Identifying Ultrasonographic Fatty Liver in a Large-Scale Cross-Sectional Study in Taiwan
- (2015) Bi-Ling Yang et al. PLoS One
- Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia
- (2014) Gianni Biolo et al. CLINICAL NUTRITION
- Prevalence and associated metabolic factors of fatty liver disease in the elderly
- (2013) Zhongli Wang et al. EXPERIMENTAL GERONTOLOGY
- Frailty Assessment in the Cardiovascular Care of Older Adults
- (2013) Jonathan Afilalo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
- (2012) Lokpal S. Bhatia et al. EUROPEAN HEART JOURNAL
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
- (2012) Pontus Boström et al. NATURE
- 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
- (2011) Jeffrey L. Anderson et al. CIRCULATION
- Sarcopenia With Limited Mobility: An International Consensus
- (2011) John E. Morley et al. Journal of the American Medical Directors Association
- Insulin Resistance: the Link Between Obesity and Cardiovascular Disease
- (2011) Gerald M. Reaven MEDICAL CLINICS OF NORTH AMERICA
- The roles of obesity and gender on the relationship between metabolic risk factors and non-alcoholic fatty liver disease in Koreans
- (2009) Kayoung Lee et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now